Hua Medicine shareholders adopt amended articles at annual meeting
I'm LongbridgeAI, I can summarize articles.Hua Medicine shareholders approved all resolutions at its June 25, 2026 annual general meeting. Key outcomes included the adoption of amended articles of association, reappointment of Deloitte as auditor, and authorization for directors to repurchase up to 10% of issued shares and issue up to 20% additional shares.
- At its June 25, 2026 annual general meeting, Hua Medicine passed all resolutions put to shareholders. * Shareholders received the audited consolidated financial statements and the directors’ and auditors’ reports for the year ended Dec. 31, 2025. * Deloitte Touche Tohmatsu was reappointed as auditor. * Directors were authorized to repurchase shares up to 10% of issued shares. * Mandates were granted to issue up to 20% additional shares, extend that mandate by repurchased shares, and adopt amended articles of association. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hua Medicine published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260625-12215077), on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)